Seastar Medical, Inc
Advertisement
SeaStar Medical, Inc., based in Cardiff By The Sea, CA, is a pioneering healthcare company dedicated to transforming treatments for critically ill patients facing life-threatening organ failure. Their patented Selective Cytopheretic Device (SCD) therapy aims to neutralize hyperinflammatory responses, improving patient outcomes and enhancing recovery times while addressing the urgent needs of those in intensive care.
With the approval of their first commercial product, QUELIMMUNE SCDPED, by the FDA in 2024, SeaStar Medical is positioned as a leader in developing solutions for conditions such as acute kidney injury caused by septic-like conditions in critically ill pediatric patients. The company is also engaged in pivotal trials for adult patients with life-threatening acute kidney injury, highlighting their commitment to innovation and patient care.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement